Literature DB >> 25031446

The Bristol stool scale and its relationship to Clostridium difficile infection.

Daniel A Caroff1, Paul H Edelstein2, Keith Hamilton3, David A Pegues4.   

Abstract

The Bristol stool form scale classifies the relative density of stool samples. In a prospective cohort study, we investigated the associations between stool density, C. difficile assay positivity, hospital-onset C. difficile infection, complications, and severity of C. difficile. We describe associations between the Bristol score, assay positivity, and clinical C. difficile infection.
Copyright © 2014, American Society for Microbiology. All Rights Reserved.

Entities:  

Mesh：

Year:  2014        PMID： 25031446      PMCID： PMC4313178          DOI： 10.1128/JCM.01303-14

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN： 0095-1137            Impact factor:   5.948


  6 in total

1.  Detection of pseudodiarrhoea by simple clinical assessment of intestinal transit rate.

Authors:  L J O'Donnell; J Virjee; K W Heaton
Journal:  BMJ       Date:  1990-02-17

2.  European Society of Clinical Microbiology and Infectious Diseases (ESCMID): treatment guidance document for Clostridium difficile infection (CDI).

Authors:  M P Bauer; E J Kuijper; J T van Dissel
Journal:  Clin Microbiol Infect       Date:  2009-12       Impact factor: 8.067

3.  Stool form scale as a useful guide to intestinal transit time.

Authors:  S J Lewis; K W Heaton
Journal:  Scand J Gastroenterol       Date:  1997-09       Impact factor: 2.423

4.  Loop-mediated isothermal amplification compared to real-time PCR and enzyme immunoassay for toxigenic Clostridium difficile detection.

Authors:  Bobby L Boyanton; Preethi Sural; Caroline R Loomis; Christine Pesta; Laura Gonzalez-Krellwitz; Barbara Robinson-Dunn; Paul Riska
Journal:  J Clin Microbiol       Date:  2011-12-21       Impact factor: 5.948

5.  How well does stool form reflect colonic transit?

Authors:  L P Degen; S F Phillips
Journal:  Gut       Date:  1996-07       Impact factor: 23.059

6.  A comparison of vancomycin and metronidazole for the treatment of Clostridium difficile-associated diarrhea, stratified by disease severity.

Authors:  Fred A Zar; Srinivasa R Bakkanagari; K M L S T Moorthi; Melinda B Davis
Journal:  Clin Infect Dis       Date:  2007-06-19       Impact factor: 9.079
  6 in total
  10 in total

1.  Bristol Stool Form Scale reliability and agreement decreases when determining Rome III stool form designations.

Authors:  B P Chumpitazi; M M Self; D I Czyzewski; S Cejka; P R Swank; R J Shulman
Journal:  Neurogastroenterol Motil       Date:  2015-12-21       Impact factor: 3.598

2.  Clostridioides difficile Toxin B PCR Cycle Threshold as a Predictor of Toxin Testing in Stool Specimens from Hospitalized Adults.

Authors:  Sean Lee; Neha Nanda; Kenichiro Yamaguchi; Yelim Lee; Rosemary C She
Journal:  Antibiotics (Basel)       Date:  2022-04-26

Review 3.  Clostridium difficile Infection and Fecal Microbiota Transplant.

Authors:  Alyssa Liubakka; Byron P Vaughn
Journal:  AACN Adv Crit Care       Date:  2016-07

4.  Lack of Correlation between Bristol Stool Scale and Quantitative Bacterial Load in Clostridium difficile Infection.

Authors:  Abrar K Thabit; David P Nicolau
Journal:  Infect Dis (Auckl)       Date:  2015-02-26

5.  An exploratory study to evaluate Clostridium difficile polymerase chain reaction ribotypes and infection outcomes.

Authors:  Abrar K Thabit; David P Nicolau
Journal:  Infect Drug Resist       Date:  2016-06-27       Impact factor: 4.003

Review 6.  Current knowledge on the laboratory diagnosis of Clostridium difficile infection.

Authors:  Adrián Martínez-Meléndez; Adrián Camacho-Ortiz; Rayo Morfin-Otero; Héctor Jesús Maldonado-Garza; Licet Villarreal-Treviño; Elvira Garza-González
Journal:  World J Gastroenterol       Date:  2017-03-07       Impact factor: 5.742

7.  Heat shock protein 70 protects mouse against post-infection irritable bowel syndrome via up-regulating intestinal γδ T cell's Th17 response.

Authors:  Zhoutao He; Xiaoning Sun; Zhichao Ma; Jiao Fu; Baili Huang; Fujin Liu; Yi Chen; Taozhi Deng; Xiangyang Han; Deming Sun; Cheng Lan
Journal:  Cell Biosci       Date:  2018-06-05       Impact factor: 7.133

8.  Diarrhoea: interventions, consequences and epidemiology in the intensive care unit (DICE-ICU): a protocol for a prospective multicentre cohort study.

Authors:  Joanna C Dionne; Kristen Sullivan; Lawrence Mbuagbaw; Alyson Takaoka; Erick Huaileigh Duan; Waleed Alhazzani; John W Devlin; Matthew Duprey; Paul Moayyedi; David Armstrong; Lehana Thabane; Jennifer L Y Tsang; Roman Jaeschke; Cindy Hamielec; Tim Karachi; Rodrigo Cartin-Ceba; John Muscedere; Mohammed Saeed Saad Alshahrani; Deborah J Cook
Journal:  BMJ Open       Date:  2019-06-27       Impact factor: 2.692

9.  A retrospective study of probiotics for the treatment of children with antibiotic-associated diarrhea.

Authors:  Xue Rui; Shu-Xia Ma
Journal:  Medicine (Baltimore)       Date:  2020-06-05       Impact factor: 1.817

10.  Clostridium difficile outbreak caused by NAP1/BI/027 strain and non-027 strains in a Mexican hospital.

Authors:  Rayo Morfin-Otero; Elvira Garza-Gonzalez; Sara A Aguirre-Diaz; Rodrigo Escobedo-Sanchez; Sergio Esparza-Ahumada; Hector R Perez-Gomez; Santiago Petersen-Morfin; Esteban Gonzalez-Diaz; Adrian Martinez-Melendez; Eduardo Rodriguez-Noriega
Journal:  Braz J Infect Dis       Date:  2015-11-24       Impact factor: 3.257
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.